Effect of pentoxifylline on tumor suppressor and proto-oncogene apoptosis in sperm

David T Maxwell1, John D Jacobson, Alan King

  • 1Department of Gynecology and Obstetrics, Loma Linda University School of Medicine, California 92354, USA.

Abstract

Insights

Pentoxifylline (PTX) pretreatment protected the BRCA1 gene from DNA damage but not the c-myc proto-oncogene. This suggests PTX offers gene-specific protection against DNA damage.

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Pentoxifylline (PTX), a phosphodiesterase inhibitor, reduces superoxide anions implicated in DNA apoptosis.
  • Understanding the differential effects of PTX on specific genes is crucial for its therapeutic applications.

Purpose of the Study:

  • To evaluate the DNA integrity of the BRCA1 tumor suppressor gene and the c-myc proto-oncogene following PTX treatment.
  • To test the hypothesis that PTX equally reduces DNA damage in different cell genes.

Main Methods:

  • Sperm samples were preincubated with or without PTX and subjected to heat shock.
  • Single primer polymerase chain reaction (PCR) was used to target BRCA1 exon 11 and c-myc exon 1.
  • DNA integrity was assessed using fluorescent staining and microarray analysis.

Main Results:

  • PTX pretreatment significantly increased BRCA1 gene integrity (93.3% vs. 50.5% in controls).
  • No significant difference in c-myc gene integrity was observed between PTX-treated and control groups.
  • Both sense and antisense DNA strands showed similar fragmentation patterns.

Conclusions:

  • PTX pretreatment demonstrated a protective effect on the BRCA1 gene but not on the c-myc proto-oncogene.
  • The findings indicate that PTX does not equally protect all cell genes, potentially due to differences in gene fragility.
  • The DNA disc chip assay confirmed that both DNA strands were similarly affected by PTX pretreatment.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...